Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical compositions or health care product having blood sugar reduction effect

A composition and a hypoglycemic technology are applied in the field of pharmaceutical compositions or health products, and in the field of hypoglycemic pharmaceutical compositions or health products to achieve the effect of taking safety

Inactive Publication Date: 2013-02-20
北京润康普瑞生物技术有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is a lack of a pharmaceutical composition or health product that starts from the source of improving insulin sensitivity, significantly controls blood sugar and lowers lipids, and fundamentally solves the worries of diabetics

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical compositions or health care product having blood sugar reduction effect
  • Pharmaceutical compositions or health care product having blood sugar reduction effect
  • Pharmaceutical compositions or health care product having blood sugar reduction effect

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Preparation of powder

[0059] Weigh each component: 260 parts of bitter melon extract, 290 parts of olive extract, 230 parts of cinnamon extract, 150 parts of guava extract, 140 parts of tartary buckwheat extract, 20 parts of astaxanthin, 20 parts of lutein , 10 parts of chromium-containing yeast, 2500 parts of xylitol.

[0060] Mix well, put it into a bag, and get it; the amount of each bag is 2.5g.

Embodiment 2

[0062] Preparation of granules

[0063] 320 parts of bitter melon extract, 400 parts of olive extract, 340 parts of cinnamon extract, 200 parts of guava extract, 200 parts of tartary buckwheat extract, 40 parts of astaxanthin, 25 parts of lutein, 13 parts of chromium-containing yeast, Xylitol 2800 parts.

[0064] Mix the above-mentioned components evenly, make granules, pack, and obtain, and the amount of each bag is 2.5g.

Embodiment 3

[0066] Preparation of granules

[0067] Weigh each component: 380 parts of bitter melon extract, 450 parts of olive extract, 380 parts of cinnamon extract, 245 parts of guava extract, 220 parts of tartary buckwheat extract, 50 parts of astaxanthin, 33 parts of lutein, 17 parts of chromium-containing yeast and 3000 parts of xylitol.

[0068] Mix the above-mentioned components evenly, make granules, pack, and obtain, and the amount of each bag is 2.5g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition or health care product having a blood sugar reduction effect. The pharmaceutical composition contains the following components in parts by weight: 260-520 parts of momordica charantia extract, 290-600 parts of olive extract, 230-540 parts of cinnamon extract, 150-280 parts of guava extract, 140-310 parts of tartary buckwheat extract, 20-80 parts of astaxanthin, 20-40 parts of lutein, 10-25 parts of chromium-containing yeast, and 2500-3800 parts of xylitol. After being added with auxiliary materials or carries required for preparation forming, the pharmaceutical composition disclosed by the invention can be prepared into any suitable pharmaceutical preparation acceptable clinically according to a conventional preparation method in the field. Proved by pharmacology test result, the pharmaceutical composition or health care product has good effect of reducing blood sugar, has no toxic or side effect on animals, and is safe to take.

Description

technical field [0001] The invention relates to a pharmaceutical composition or a health product, in particular to a pharmaceutical composition or a health product with the function of lowering blood sugar, and belongs to the field of a blood sugar lowering pharmaceutical composition or health product. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by elevated blood sugar caused by defects in insulin secretion and (or) action. It is a comprehensive chronic disease mainly characterized by disorders of glucose metabolism. Diabetic patients with long-term poor blood sugar control may be accompanied by various organs, especially eye, heart, blood vessel, kidney, nerve damage or organ insufficiency or failure, resulting in disability or premature death. [0003] In recent years, with the development of social economy and the improvement of residents' living standards in all countries in the world, the incidence and prevalence of diabetes have...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/70A61P3/10A23L1/09
Inventor 王志文
Owner 北京润康普瑞生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products